| 000 | 01501 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512034809.0 | ||
| 264 | 0 | _c19871019 | |
| 008 | 198710s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1987.5.8.1303 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalloum, E | |
| 245 | 0 | 0 |
_aIrreversible encephalopathy with ifosfamide/mesna. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cAug 1987 |
||
| 300 |
_a1303-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBrain Diseases _xchemically induced |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDactinomycin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
| 650 | 0 | 4 |
_aMaxillary Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMercaptoethanol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMesna _xadministration & dosage |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aFlamant, F | |
| 700 | 1 | _aGhosn, M | |
| 700 | 1 | _aTaleb, N | |
| 700 | 1 | _aAkatchereian, C | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 5 _gno. 8 _gp. 1303-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1987.5.8.1303 _zAvailable from publisher's website |
| 999 |
_c3120235 _d3120235 |
||